Overview
PaCaReg is a multicenter registry trial aiming in the assessement of clinical, epidemiological and biological profiles in patients with pancreatic ductal adenocarcinoma
Eligibility
Inclusion Criteria:
- Treatment naive histologically or cytologically proven pancreatic ductal adenocarcinoma (PDAC) or highly suspicious diagnosis (only pre-curative-intended resection)
- Age =>18 years
- written informed consent
Exclusion Criteria:
- papillary cancer
- neuroendocrine pancreatic tumors